C. Xue et al. / Tetrahedron 64 (2008) 248e254
253
4.1.3. 2-{[2-(3,3-Dimethyl-3-silabut-1-ynyl)-
phenyl]methoxy}-1-iodobenzene
128.76, 129.35, 134.01, 136.04, 139.51, 145.64, 157.13 ppm;
EI-GCeMS (25 eV) m/z 462 (Mþ), 461, 447, 401, 327,
243, 207; HRMS calcd for C21H23O3BI 461.0785, found
461.0781.
1H NMR (CDCl3, TMS) d 0.25 (s, 9H), 5.29 (s, 2H), 6.67
(t, J¼7.5 Hz, 1H), 6.83 (d, J¼8 Hz, 1H), 7.22 (t, J¼8 Hz, 1H),
7.25 (t, J¼8 Hz, 1H), 7.34 (t, J¼7.5 Hz, 1H), 7.47 (d,
J¼7.5 Hz, 1H), 7.67 (d, J¼7.5 Hz, 1H), 7.77 (d, J¼7.5 Hz,
1H) ppm; 13C NMR (CDCl3, TMS) d 0.22, 69.08, 86.83,
100.37, 102.35, 112.61, 121.11, 122.95, 127.19, 127.60,
129.16, 129.65, 132.27, 138.85, 139.73, 157.28 ppm; MS
m/z 406 (Mþ), 264, 249, 219, 187, 159; HRMS calcd for
C18H19OISi 406.0250, found 406.0248.
4.1.6. 2-(6H-Dibenzo[c,f]oxepan-11-ylidenemethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (2)
The procedure was similar to that for the preparation of 3
except stirring the reaction for another 3 h after dropwise add-
ing all the chemicals at 70 ꢀC. The above reaction mixture was
quenched by dropwise adding water at 0 ꢀC and followed by
adding ethyl acetate. The organic layer was separated, drying
over magnesium sulfate, filtrated, and concentrated at lower
pressure. The residue was purified by column chromatography
(hexane/ethyl acetate¼30:1) to afford the title compound
(0.34 g, 1.0 mmol) as a white solid in 51% yield: mp 43e
45 ꢀC. 1H NMR (CDCl3, TMS) d 1.33 (s, 12H), 5.35 (s,
2H), 6.77 (t, J¼7 Hz, 1H), 6.79 (d, J¼7 Hz, 1H), 7.00 (t,
J¼7 Hz, 1H), 7.01 (d, J¼7 Hz, 1H), 7.22 (t, J¼7 Hz, 1H),
7.28 (d, J¼7 Hz, 1H), 7.30 (t, J¼7 Hz, 1H), 7.44 (d,
J¼7 Hz, 1H), 7.50 (s, 1H) ppm; 13C NMR (CDCl3, TMS)
d 24.80, 70.41, 83.95, 120.05, 120.45, 124.18, 127.09,
128.32, 128.88, 129.25, 130.74, 132.62, 134.22, 141.61,
145.39, 154.80, 181.51 ppm; EI-GCeMS (25 eV) m/z 334
(Mþ), 234, 233, 215; HRMS calcd for C21H23O3B 334.1740,
found 334.1742.
4.1.4. 2-[(2-Ethynylphenyl)methoxy]-1-iodobenzene (1)
To a solution of 2-iodophenol (1.10 g, 5 mmol), K2CO3
(0.81 g, 5.9 mmol) in acetone (10 mL) under nitrogen atmo-
sphere was added dropwise a solution of 2-[(trimethylsilyl)-
ethynyl]benzyl bromide18 (1.20 g, 4.5 mmol) in 5 mL of
acetone at room temperature and the resulting mixture was re-
fluxed with stirring for another 12 h. The volatile material was
removed by rotavap and the residue was recrystallized via
methanol to afford the title compound (1.09 g, 3.3 mmol) as
1
a white solid in 65% yield: mp 58e60 ꢀC. H NMR (CDCl3,
TMS) d 3.39 (s, 1H), 5.36 (s, 2H), 6.74 (t, J¼7 Hz, 1H),
6.90 (d, J¼7 Hz, 1H), 7.30 (t, J¼7 Hz, 2H), 7.43 (t, J¼7 Hz,
1H), 7.54 (d, J¼7 Hz, 1H), 7.80 (d, J¼7 Hz, 1H), 7.83 (d,
J¼7 Hz, 1H) ppm; 13C NMR (CDCl3, TMS) d 68.75, 80.79,
82.66, 86.60, 112.64, 119.60, 122.83, 126.94, 127.39,
129.27, 129.44, 132.53, 138.90, 139.52, 156.98 ppm; MS
m/z 334 (Mþ), 207, 115; HRMS calcd for C15H11OI 333.9855,
found 333.9853. Anal. Calcd for C15H11OI: C, 53.92; H,
3.32. Found: C, 53.85; H, 3.37.
4.1.7. (E)-Doxepin
To a mixture of Pd(dba)2 (29 mg, 0.05 mmol), PCy3
(28 mg, 0.1 mmol), K3PO4 (1.28 g, 6 mmol) in 10 mL of dry
THF was added 2-bromo-N,N-dimethylacetamide16 (0.25 g,
1.5 mmol) at 70 ꢀC. After stirring for 20 min, the alkenylbor-
onate 2 (0.33 g, 1 mmol) in 5 mL of THF was added and the
mixture was stirred for another 16 h at 70 ꢀC. The mixture
was quenched with water, extracted with EtOAc, and purified
by flash column chromatography (hexane/EtOAc¼2:1). After
removing the volatile solvents and without further purification
of the residue, the crude amide (0.23 g, 0.78 mmol), LiAlH4
(0.11 g, 3 mmol), and THF (10 mL) were stirred for 48 h at
room temperature. The mixture was treated with AcOEt
(1 mL) and 10% NaOH (2 mL) and then extracted with ether
(10 mLꢁ3). The extraction layers were combined and dried
over MgSO4 and concentrated to give 0.12 g (42%) of (E)-
4.1.5. 2-({2-[(1E)-2-(4,4,5,5-Tetramethyl(1,3,2-dioxa-
borolan-2-yl))vinyl]phenyl}methoxy)-1-iodobenzene (3)
To a pre-heated solution of bis(pinacolato)diboron (1.02 g,
4 mmol) and potassium acetate (0.39 g, 5 mmol) in DMSO
(20 mL) under nitrogen atmosphere in 100 mL of two-necked
round-bottomed flask at 70 ꢀC was dropwise added a solution
of PdCl2(dppf) (dichloro[1,10-bis(diphenylphosphino)ferroce-
ne]palladium(II)) (22 mg, 0.03 mmol) and P(t-Bu)3 (12 mg,
0.06 mmol) in 10 mL of DMSO and followed by the addition
of a solution of 2-[(2-ethynylphenyl)methoxy]-1-iodobenzene
1 (0.67 g, 2 mmol) in 7 mL of DMSO and keep stirring for an-
other half an hour at 70 ꢀC. The above reaction mixture was
dropwise added into a stirring solution of ethyl acetate
(100 mL) and water (100 mL) at 0 ꢀC. After stirring for an-
other 10 min, the organic layer was separated, drying over
magnesium sulfate, filtrated, and concentrated at lower pres-
sure. The residue was purified by column chromatography
(hexane/ethyl acetate¼50:1) to afford the title compound
(0.65 g, 1.4 mmol) as a pale yellow solid in 70% yield: mp
1
doxepin as a colorless oil: H NMR (CDCl3, TMS) d 2.26
(s, 6H), 2.35e2.45 (m, 2H), 2.45e2.55 (m, 2H), 4.72 (br s,
1H), 5.50 (br s, 1H), 5.97 (t, J¼7 Hz, 1H), 6.73 (d, J¼7 Hz,
1H), 6.85 (t, J¼7 Hz, 1H), 7.10 (t, J¼7 Hz, 1H), 7.20 (d,
J¼7 Hz, 1H), 7.24 (d, J¼7 Hz, 1H), 7.28 (t, J¼7 Hz, 1H),
7.31 (t, J¼7 Hz, 1H), 7.33 (d, J¼7 Hz, 1H) ppm; 13C NMR
(CDCl3, TMS) d 26.96, 44.75 (2C0s), 58.82, 70.24, 119.39,
121.23, 127.20, 127.90, 128.18, 128.30, 128.46, 128.85,
129.39, 130.27, 134.43, 141.04, 141.26, 155.29 ppm; EI-
GCeMS m/z 279 (Mþ), 277, 219, 202, 189, 178, 165, 152,
139, 128, 115, 58; FAB m/z 280 (Mþþ1); HRMS calcd for
C19H22ON 280.1701, found 280.1697.
1
47e49 ꢀC. H NMR (CDCl3, TMS) d 1.31 (s, 12H), 5.28 (s,
2H), 6.13 (d, J¼18 Hz, 1H), 6.73 (t, J¼8 Hz, 1H), 6.90 (d,
J¼8 Hz, 1H), 7.28 (t, J¼8 Hz, 1H), 7.30e7.36 (m, 2H), 7.61
(d, J¼8 Hz, 2H), 7.65 (d, J¼18 Hz, 1H), 7.79 (d, J¼8 Hz,
1H) ppm; 13C NMR (CDCl3, TMS) d 24.80, 68.77, 83.41,
86.86, 113.13, 120.00, 122.87, 126.28, 127.89, 128.08,